Stéphane Gagné

Stéphane Gagné has extensive experience in the biotechnology and pharmaceutical industries. Stéphane is currently the Founder, President, and CEO of Immugenia Inc., an immuno-oncology company focused on developing CAR therapy for cancer treatment. Prior to this, they founded and served as President and CEO of Ovensa Inc., a biotechnology company specializing in enhancing the delivery of biologics and small molecules. Stéphane also served as the President and Owner of Partenaris Inc., a strategic development and commercialization company in the functional food and cosmeceuticals fields. Stéphane has held various leadership roles at Radient Technologies Inc., Advitech Inc. - Botaneco Corp., Constab Pharmaceutical Inc., Constab International Inc., Atrium Biotechnologies, Atrium Innovations, and Aeterna Laboratories Inc., where they contributed to business development, sales, marketing, and strategic partnerships.

Stéphane Gagné obtained a B.Sc. and Master's degree in Economics, Business, Marketing, Communications, and Languages from Université de Sherbrooke from 1991 to 1994. Prior to that, they completed their DEC in Sciences with Mathematics at CEGEP de Sherbrooke from 1988 to 1990. No information is available about their education before CEGEP.